WashU researchers honored with NIH Director’s Awards
Three WashU investigators have been recognized with prestigious awards through the National Institutes of Health (NIH) Director’s High-Risk, High-Reward Research program, which supports unconventional approaches to major challenges in biomedical and behavioral research.
Researchers find key to stopping deadly infection
New research from WashU Medicine identified a key enzyme that enables rotavirus to infect cells. Disabling this enzyme prevented infection, suggesting new treatments against rotavirus and other pathogens that rely on similar mechanisms.
An inside look at the earliest stage of life
Researchers at Washington University in St. Louis have a developed a way to monitor mouse embryo development and predict successful blastocyst formation. The results of the study could help improve success rates of in vitro fertilization.
Body’s garbage-collecting cells protect insulin production in pancreas
WashU Medicine researchers found that immune cells that dispose of the body’s cellular debris can protect insulin-producing cells and prevent Type 1 diabetes in mice.
Kelly to lead Division of Maternal-Fetal Medicine & Ultrasound
Jeannie Kelly, MD, a renowned expert in the care of women with opiate use disorders during pregnancy, has been named the new director of the Division of Maternal-Fetal Medicine & Ultrasound in the Department of Obstetrics & Gynecology at WashU Medicine.
$5 million funds innovation of more-potent opioid overdose antidote
WashU Medicine researchers received a grant from the National Institutes of Health (NIH) that will help speed development of an enhanced version of naloxone, known by the brand name Narcan.
Tracking deadly and unpredictable postpartum hemorrhage
Researchers at Washington University in St. Louis are developing a wearable device that aims to track blood loss in pregnant women during delivery, with support from a $2.8 million grant from the National Institutes of Health (NIH). The device aids in early warning signs for postpartum hemorrhage, a birth complication that is the leading cause of maternal death worldwide.
Wearable imaging system could provide insight into preterm birth
A team of researchers at Washington University in St. Louis is developing an at-home wearable device that would monitor electrical and mechanical signals in the uterus during pregnancy and labor, with a four-year $920,769 grant from the National Institutes of Health (NIH).
Novel way to ‘rev up’ brown fat burns calories, limits obesity in mice
A new study led by researchers at WashU Medicine reveals possible new avenues to help brown fat produce more heat, which could aid in weight loss and improve metabolic health.
$4.87 million grant supports development of sepsis diagnostic device
A U.S. Department of Defense award will help WashU Medicine researchers develop a test to quickly group sepsis patients into risk categories based on their levels of two inflammatory biomarkers.
Older Stories